CLINICAL_TRIALS
trial_result
· 2025-01-03
Clinical Trial Update: Treatment Shortening of MDR-TB Using Existing and New Drugs [Phase 2]
Summary
Phase 2 trial evaluating shortening treatment for multidrug-resistant tuberculosis using existing and new drugs; the study is completed and results have been po…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Seoul National University Hospital | Conditions: Tuberculosis, Multidrug-Resistant | Phase 2 | Status: COMPLETED | Results posted: 2025-01-03